BACKGROUND/AIMS: Paediatric primary follicular lymphoma of the testis (PPFLT) is exceptional: the few reported cases seem to lack BCL-2 gene rearrangement and/or protein expression. The aim of this study was to characterise a PPFLT arising in a 4 year old boy. METHODS: This case was characterised using conventional histological analysis, immunohistochemistry, and a polymerase chain reaction based method for the detection of immunoglobulin V(H) chain rearrangements. RESULTS: The neoplasm was staged I(E)/A; left orchiectomy and chemotherapy were performed, producing complete remission. Histology showed a predominantly follicular lymphoid infiltrate mainly composed of centroblast-like cells. The phenotype was CD20(+), CD79a(+), CD10(+), bcl-6(+), B cell specific activating protein(+), kappa light chain(+), CD30(-/+), interferon regulating factor 4(-/+), c-myc(-/+), lambda light chain(-), CD3(-), bcl-2(-), p53(-), cytokeratin(-), and placental alkaline phosphatase(-). Lymphomatous elements were found within a CD21(+) follicular dendritic cell network and 70% were positive for Ki-67/MIB-1. Molecular analysis revealed monoclonal immunoglobulin heavy chain gene rearrangement and BCL-6 mutations, in the absence of BCL-2 major breakpoint and BCL-2 minor cluster region rearrangements, p53 mutations, and death associated protein kinase gene hypermethylation. CONCLUSIONS: These findings suggest a different pathogenesis of PPTFL compared with adult follicular lymphoma and might explain its favourable course in spite of aggressive histology.
BACKGROUND/AIMS: Paediatric primary follicular lymphoma of the testis (PPFLT) is exceptional: the few reported cases seem to lack BCL-2 gene rearrangement and/or protein expression. The aim of this study was to characterise a PPFLT arising in a 4 year old boy. METHODS: This case was characterised using conventional histological analysis, immunohistochemistry, and a polymerase chain reaction based method for the detection of immunoglobulin V(H) chain rearrangements. RESULTS: The neoplasm was staged I(E)/A; left orchiectomy and chemotherapy were performed, producing complete remission. Histology showed a predominantly follicular lymphoid infiltrate mainly composed of centroblast-like cells. The phenotype was CD20(+), CD79a(+), CD10(+), bcl-6(+), B cell specific activating protein(+), kappa light chain(+), CD30(-/+), interferon regulating factor 4(-/+), c-myc(-/+), lambda light chain(-), CD3(-), bcl-2(-), p53(-), cytokeratin(-), and placental alkaline phosphatase(-). Lymphomatous elements were found within a CD21(+) follicular dendritic cell network and 70% were positive for Ki-67/MIB-1. Molecular analysis revealed monoclonal immunoglobulin heavy chain gene rearrangement and BCL-6 mutations, in the absence of BCL-2 major breakpoint and BCL-2 minor cluster region rearrangements, p53 mutations, and death associated protein kinase gene hypermethylation. CONCLUSIONS: These findings suggest a different pathogenesis of PPTFL compared with adult follicular lymphoma and might explain its favourable course in spite of aggressive histology.
Authors: S A Pileri; P L Zinzani; S Ascani; G F Orcioni; B Gamberi; M Piccioli; E Sabattini; S Poggi; P P Piccaluga; B Falini Journal: Ann Oncol Date: 2001-10 Impact factor: 32.976
Authors: Hervé Husson; Elizabeth G Carideo; Donna Neuberg; Joachim Schultze; Olivier Munoz; Peter W Marks; John W Donovan; Antoinette C Chillemi; Peter O'Connell; Arnold S Freedman Journal: Blood Date: 2002-01-01 Impact factor: 22.113
Authors: G Gaidano; P Ballerini; J Z Gong; G Inghirami; A Neri; E W Newcomb; I T Magrath; D M Knowles; R Dalla-Favera Journal: Proc Natl Acad Sci U S A Date: 1991-06-15 Impact factor: 11.205
Authors: P G Corn; S J Kuerbitz; M M van Noesel; M Esteller; N Compitello; S B Baylin; J G Herman Journal: Cancer Res Date: 1999-07-15 Impact factor: 12.701
Authors: Manel Esteller; Gianluca Gaidano; Steven N Goodman; Vittorina Zagonel; Daniela Capello; Barbara Botto; Davide Rossi; Annunziata Gloghini; Umberto Vitolo; Antonino Carbone; Stephen B Baylin; James G Herman Journal: J Natl Cancer Inst Date: 2002-01-02 Impact factor: 13.506
Authors: E Pescarmona; V De Sanctis; A Pistilli; A Pacchiarotti; M Martelli; C Guglielmi; F Mandelli; C D Baroni; F Le Coco Journal: J Pathol Date: 1997-11 Impact factor: 7.996
Authors: A Reiter; M Schrappe; R Parwaresch; G Henze; S Müller-Weihrich; S Sauter; K W Sykora; W D Ludwig; H Gadner; H Riehm Journal: J Clin Oncol Date: 1995-02 Impact factor: 44.544
Authors: Alejandro Vara Castrodeza; Angeles Torres Nieto; Marcelino Mendo González; Antonio Rodríguez Toves; María Jesús Peñarrubia Ponce; Miguel Angel de la Fuente Bobillo Journal: Clin Transl Oncol Date: 2006-06 Impact factor: 3.405
Authors: Mark A Lones; Martine Raphael; Keith McCarthy; Andrew Wotherspoon; Marie-Josee Terrier-Lacombe; Alan D Ramsay; Ken Maclennan; Mitchell S Cairo; Mary Gerrard; Jean Michon; Catherine Patte; Ross Pinkerton; Leonard Sender; Anne Auperin; Richard Sposto; Claire Weston; Nyla A Heerema; Warren G Sanger; Daniel von Allmen; Sherrie L Perkins Journal: J Pediatr Hematol Oncol Date: 2012-01 Impact factor: 1.289
Authors: Kathryn A Rizzo; Berthold Streubel; Stefania Pittaluga; Andreas Chott; Liqiang Xi; Mark Raffeld; Elaine S Jaffe Journal: Mod Pathol Date: 2010-03-19 Impact factor: 7.842
Authors: Leticia Quintanilla-Martinez; Birgitta Sander; John K C Chan; Luc Xerri; German Ott; Elias Campo; Steven H Swerdlow Journal: Virchows Arch Date: 2015-09-28 Impact factor: 4.064
Authors: E Campo; A Chott; M C Kinney; L Leoncini; C J L M Meijer; C S Papadimitriou; M A Piris; H Stein; S H Swerdlow Journal: Histopathology Date: 2006-04 Impact factor: 5.087